Patent details

EP1200091 Title: PHARMACEUTICAL COMPOSITION COMPRISING TADALAFIL

Basic Information

Publication number:
EP1200091
PCT Application Number:
PCT/US/2000/011136
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP009263716
PCT Publication Number:
WO/2001/008687
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PHARMACEUTICAL COMPOSITION COMPRISING TADALAFIL
French Title of Invention:
COMPOSITION PHARMACEUTIQUE A BASE DE TADALAFIL
German Title of Invention:
PHARMAZEUTISCHE ZUSAMMENSETZUNG ENTHALTEND TADALAFIL
SPC Number:

Dates

Filing date:
26/04/2000
Grant date:
02/07/2008
EP Publication Date:
02/07/2008
PCT Publication Date:
08/02/2001
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
02/05/2002
EP B1 Publication Date:
02/07/2008
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
26/04/2009
Expiration date:
26/04/2020
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
26/04/2000
 
 

Name:
Lilly Icos LLC
Address:
1209 Orange Street, Wilmington, DE 19801, United States (US)

Inventor

1

Name:
GULLAPALLI Rampurna, P.
Address:
United States (US)

2

Name:
ANDERSON Neil, R.
Address:
United States (US)

Priority

Priority Number:
146924 P
Priority Date:
03/08/1999
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/4985;
Filing date Document type Number of pages